Gene · 8295
Papers1,639
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,639
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of primary synchronous breast invasive ductal carcinoma and lung adenocarcinoma with next-generation sequencing: A case report. | Oncol Lett | 2023 | 36478904 | PubTator, text mining | PubMed |
| TTI1 promotes non-small-cell lung cancer progression by regulating the mTOR signaling pathway. | Cancer Sci | 2023 | 36403197 | PubTator, text mining | PubMed |
| SMG1, a nonsense-mediated mRNA decay (NMD) regulator, as a candidate therapeutic target in multiple myeloma. | Mol Oncol | 2023 | 36400430 | PubTator, text mining | PubMed |
| Genetic heterogeneity of liver cancer stem cells. | Anat Cell Biol | 2023 | 36384888 | PubTator, text mining | PubMed |
| A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications. | Thyroid | 2023 | 36322786 | PubTator, text mining | PubMed |
| Targeting Transcription Factors in Cancer: From "Undruggable" to "Druggable". | Methods Mol Biol | 2023 | 36264492 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Emerging role and therapeutic implication of mTOR signalling in intervertebral disc degeneration. | Cell Prolif | 2023 | 36193577 | PubTator, text mining | PubMed |
| Mediator subunit MED1 differentially modulates mutant thyroid hormone receptor intracellular dynamics in Resistance to Thyroid Hormone syndrome. | Mol Cell Endocrinol | 2023 | 36191835 | PubTator, text mining | PubMed |
| ATM c.7570G>C is a high-risk allele for breast cancer. | Int J Cancer | 2023 | 36161273 | PubTator, text mining | PubMed |
| Morphological and Functional Colonic Defects Caused by a Mutated Thyroid Hormone Receptor α. | Thyroid | 2023 | 36103385 | PubTator, text mining | PubMed |
| BRD4 and MYC: power couple in transcription and disease. | FEBS J | 2023 | 35866356 | PubTator, text mining | PubMed |
| Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer. | Endocr Oncol | 2022 | 37435460 | PubTator, text mining | PubMed |
| Construction of PARPi Resistance-related Competing Endogenous RNA Network. | Curr Genomics | 2022 | 36777878 | PubTator, text mining | PubMed |
| [Chinese guideline for diagnosis and treatment of lymphoplasmacytic lymphoma/Walderström macroglobulinemia (2022)]. | Zhonghua Xue Ye Xue Za Zhi | 2022 | 36709145 | PubTator, text mining | PubMed |
| Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background. | Front Endocrinol (Lausanne) | 2022 | 36686473 | PubTator, text mining | PubMed |
| Next-Generation Sequencing in the Assessment of the Transcriptomic Landscape of DNA Damage Repair Genes in Abdominal Aortic Aneurysm, Chronic Venous Disease and Lower Extremity Artery Disease. | Int J Mol Sci | 2022 | 36614026 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and genetic alterations in clear cell carcinoma cells derived from Mullerian duct epithelium of the prostate. | Chin Med J (Engl) | 2022 | 36583865 | PubTator, text mining | PubMed |
| Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients. | Front Oncol | 2022 | 36578946 | PubTator, text mining | PubMed |
| The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance. | Front Immunol | 2022 | 36569948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8295/papers?page=9